Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01992653
Title A Study of Polatuzumab Vedotin in Combination With Rituximab or Obinutuzumab, Cyclophosphamide, Doxorubicin, and Prednisone in Participants With B-Cell Non-Hodgkin's Lymphoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Genentech, Inc.
Indications
Therapies
Age Groups: senior
Covered Countries USA | FRA

Facility Status City State Zip Country Details
The University of Alabama at Birmingham Birmingham Alabama 35233 United States Details
Banner MD Anderson Cancer Center Greeley Colorado 85234 United States Details
Washington University; Pediatrics Saint Louis Missouri 63110 United States Details
Northwest Cancer Specialists Portland Oregon 97210 United States Details
Oregon Health and Science University Portland Oregon 97239 United States Details
Willamette Valley Clinical Studies; Cancer Institute Springfield Oregon 97477 United States Details
Blue Ridge Cancer Care Roanoke Virginia 24014 United States Details
Hopital Henri Mondor, Unite Hemopathies lymphoides Creteil 94010 France Details
Hopital Claude Huriez - CHU Lille; Service des maladies du sang Lille 59037 France Details
Centre Hospitalier Lyon Sud; Hematolgie Pierre Benite 69495 France Details
Centre Henri Becquerel; Hematologie Rouen 76038 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field